COMPARING THE OUTCOMES EXPERIENCED IN SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR KIDNEY OUTCOME TRIALS TO A CANADIAN CHRONIC KIDNEY DISEASE COHORT

被引：0
|
作者：
Yi, Tae Won [1 ,2 ]
Atiquzzaman, Mohammad [3 ]
Zheng, Yuyan [3 ]
Smyth, Brendan [2 ,4 ]
Jardine, Meg [2 ,5 ]
Levin, Adeera [2 ,3 ,6 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[2] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[3] BC Prov Renal Agcy, Vancouver, BC, Canada
[4] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia
[5] Concord Repatriat Gen Hosp, Dept Nephrol, Sydney, NSW, Australia
[6] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
来源：
NEPHROLOGY | 2022年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [1] Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study
    Yi, Tae Won
    Atiquzzaman, Mohammad
    Zheng, Yuyan
    Smyth, Brendan
    Jardine, Meg
    Levin, Adeera
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2022, 9
  • [2] Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
    Shivakumar, Oshini
    Sattar, Naveed
    Wheeler, David C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 43 - 47
  • [3] Sodium-glucose cotransporter-2 inhibitors Use in patients with chronic kidney disease
    Falk, Jamie
    Klarenbach, Scott
    Lam, Cynthia
    Potter, Jennifer
    CANADIAN FAMILY PHYSICIAN, 2022, 68 (10) : 753 - 753
  • [4] Kidney Outcomes with Sodium-Glucose Cotransporter-2 Inhibitor Initiation after AKI among Veterans with Diabetic Kidney Disease
    Murphy, Daniel P.
    Wolfson, Julian
    Reule, Scott
    Johansen, Kirsten L.
    Ishani, Areef
    Drawz, Paul E.
    KIDNEY360, 2024, 5 (03): : 335 - 343
  • [5] Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
    Cowan, Andrea
    Jeyakumar, Nivethika
    Kang, Yuguang
    Dixon, Stephanie N.
    Garg, Amit X.
    Naylor, Kyla
    Weir, Matthew A.
    Clemens, Kristin K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (06): : 835 - 842
  • [6] Sodium-Glucose Cotransporter-2 Inhibitors Utilization and Outcomes in Patients with Chronic Kidney Disease at a Tertiary Centre
    Kuan, L. Yee
    Abdul, A. G. Halim
    MEDICINE AND HEALTH, 2023, 18 (02): : 386 - 393
  • [7] Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
    Zhou, Tianbiao
    Yao, Kaijin
    Xie, Yina
    Lin, Yongda
    Wang, Jiali
    Chen, Xiutian
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (21) : 1659 - 1670
  • [8] Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease
    Rastogi, Anjay
    Januzzi, James L., Jr.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [9] Emerging sodium-glucose cotransporter-2 inhibitor therapies for managing heart failure in patients with chronic kidney disease
    Chan, Jeffrey Shi Kai
    Perone, Francesco
    Bayatpoor, Yasmin
    Tse, Gary
    Harky, Amer
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (08) : 935 - 945
  • [10] The sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease with or without kidney transplantation - a single centre study
    Kleinova, Patricia
    Granak, Karol
    Vnucak, Matej
    Beliancinova, Monika
    Blichova, Timea
    Dedinska, Ivana
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (12): : 759 - 765
12345